Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Adult-Onset Very-Long-Chain Acyl-Coa Dehydrogenase Deficiency (Vlcadd) Publisher Pubmed



Fatehi F1 ; Okhovat AA1 ; Nilipour Y2, 3 ; Mroczek M4 ; Straub V4 ; Topf A4 ; Palibrk A5 ; Peric S5 ; Rakocevic Stojanovic V5 ; Najmabadi H6 ; Nafissi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Pediatric Pathology Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Mofid Children Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
  5. 5. Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  6. 6. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Source: European Journal of Neurology Published:2020


Abstract

Background and purpose: Very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a hereditary disorder of mitochondrial long-chain fatty acid oxidation that has variable presentations, including exercise intolerance, cardiomyopathy and liver disease. The aim of this study was to describe the clinical and genetic manifestations of six patients with adult-onset VLCADD. Methods: In this study, the clinical, pathological and genetic findings of six adult patients (four from Iran and two from Serbia) with VLCADD and their response to treatment are described. Results: The median (range) age of patients at first visit was 31 (27–38) years, and the median (range) age of onset was 26.5 (19–33) years. Parental consanguinity was present for four patients. Four patients had a history of rhabdomyolysis, and the recorded CK level ranged between 67 and 90 000 IU/l. Three patients had a history of exertional myalgia, and one patient had a non-fluctuating weakness. Through next-generation sequencing analysis, we identified six cases with variants in the ACADVL gene and a confirmed diagnosis of VLCADD. Of the total six variants identified, five were missense, and one was a novel frameshift mutation identified in two unrelated individuals. Two variants were novel, and three were previously reported. We treated the patients with a combination of L-carnitine, Coenzyme Q10 and riboflavin. Three patients responded favorably to the treatment. Conclusion: Adult-onset VLCADD is a rare entity with various presentations. Patients may respond favorably to a cocktail of L-carnitine, Coenzyme Q10, and riboflavin. © 2020 European Academy of Neurology
Related Docs
View other Related Docs
1. Genetic Testing of Leukodystrophies Unraveling Extensive Heterogeneity in a Large Cohort and Report of Five Common Diseases and 38 Novel Variants, Scientific Reports (2021)
2. Identification of a Novel Homozygous Mutation of the Bckdhb Gene in an Iranian Patient With Maple Syrup Disease Using Next-Generation Sequencing, Human Gene (2023)
3. Detection of Variants in Dystroglycanopathy-Associated Genes Through the Application of Targeted Whole-Exome Sequencing Analysis to a Large Cohort of Patients With Unexplained Limb-Girdle Muscle Weakness, Skeletal Muscle (2018)
4. A Mutational Hotspot in the Lamp2 Gene: Unravelling Intrafamilial Phenotypic Variation and Global Distribution of the C.877C>T Variant: A Descriptive Study, Cell Journal (2024)
5. Clinical and Genetic Spectrum of a Large Cohort of Patients With Δ-Sarcoglycan Muscular Dystrophy, Brain (2022)
6. Brown-Vialetto-Van Laere Syndrome and Fazio-Londe Syndrome: A Novel Mutation and in Silico Analyses, Journal of Clinical Neuroscience (2020)
7. In Silico Analysis for Determining the Deleterious Nonsynonymous Single Nucleotide Polymorphisms of Brca Genes, Molecular Biology Research Communications (2019)
8. Two Novel and Five Rare Mutations in the Non Coding Regions of the Β-Globin Gene in the Iranian Population, Hemoglobin (2020)
Experts (# of related papers)
View all Related Experts
Ali Reza Tavasoli (7)
Mahmoudreza Ashrafi (4)
Other Related Docs
9. Genotypes of European and Iranian Patients With Type 3 Von Willebrand Disease Enrolled in 3Winters-Ips, Blood Advances (2021)
10. Novel Variants Broaden the Phenotypic Spectrum of Plekhg5-Associated Neuropathies, European Journal of Neurology (2021)
11. Novel Disease-Causing Variants in a Cohort of Iranian Patients With Metachromatic Leukodystrophy and in Silico Analysis of Their Pathogenicity, Clinical Neurology and Neurosurgery (2021)
12. Identification of Six Novel Mutations in Iranian Patients With Maple Syrup Urine Disease and Their in Silico Analysis, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (2016)
13. Rpe65 and Retinal Dystrophy: Report of New and Recurrent Mutations, Journal of Gene Medicine (2020)
14. Identification of a Novel Homozygous Gls Gene Variant Associated With Developmental and Epileptic Encephalopathy (Dee) Type 71, Neurogenetics (2024)
15. Beta Thalassemia in 31,734 Cases With Hbb Gene Mutations: Pathogenic and Structural Analysis of the Common Mutations; Iran As the Crossroads of the Middle East, Blood Reviews (2016)
16. Wolman Disease Presenting With Hemophagocytic Lymphohistiocytosis Syndrome and a Novel Lipa Gene Variant: A Case Report and Review of The Literature, Journal of Medical Case Reports (2023)
17. Expanding the Clinical and Neuroimaging Features of Nkx6-2-Related Hereditary Spastic Ataxia Type 8, European Journal of Medical Genetics (2020)
18. Digenic Mutations in Junctional Epidermolysis Bullosa in an Iranian Family, Cell Journal (2021)
19. Novel Digital Anomalies, Hippocampal Atrophy, and Mutations Expand the Genotypic and Phenotypic Spectra of Cnksr2 in the Houge Type of X-Linked Syndromic Intellectual Development Disorder (Mrxshg), American Journal of Medical Genetics, Part A (2025)
20. Colq-Related Congenital Myasthenic Syndrome: An Integrative View, Neurogenetics (2023)
21. Autozygosity Mapping of Methylmalonic Acidemia Associated Genes by Short Tandem Repeat Markers Facilitates the Identification of Five Novel Mutations in an Iranian Patient Cohort, Metabolic Brain Disease (2018)
22. Use of Expanded Carrier Screening for Retrospective Diagnosis of Two Deceased Siblings With Van Maldergem Syndrome 2: Case Report, Asian Biomedicine (2022)
23. Nckap1l Defects Lead to a Novel Syndrome Combining Immunodeficiency, Lymphoproliferation, and Hyperinflammation, Journal of Experimental Medicine (2020)
24. Ellis-Van Creveld Syndrome: Report of a Case and Recurrent Variant, Journal of Gene Medicine (2020)
25. Maple Syrup Urine Disease Mutation Spectrum in a Cohort of 40 Consanguineous Patients and Insilico Analysis of Novel Mutations, Metabolic Brain Disease (2019)
26. A Homozygous Truncating Mutation in Nalcn Causing Ihprf1: Detailed Clinical Manifestations and a Review of Literature, Application of Clinical Genetics (2020)
27. Exome-Wide Copy Number Variation Analysis Identifies a Col9a1 in Frame Deletion That Is Associated With Hearing Loss, European Journal of Medical Genetics (2019)
28. Identification of a Novel Stop Loss Mutation in P2rx2 Gene in an Iranian Family With Autosomal Nonsyndromic Hearing Loss, Iranian Biomedical Journal (2021)
29. Association of Ercc2/Xpd Polymorphisms and the Risk of Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, Trial Sequential Analysis, Network Analysis, and Functional Effects, BMC Oral Health (2025)
30. A Novel Compound Heterozygote Mutation in the Arsb Gene in a Patient With Maroteaux-Lamy Syndrome and Its Insilico Evaluation, Meta Gene (2018)
31. Prediction the Functional Impacts of Highly Deleterious Non-Synonymous Variants of Tsga10 Gene, Molecular Biology Research Communications (2025)
32. Novel Abcd1 Gene Mutations in Iranian Pedigrees With X-Linked Adrenoleukodystrophy, Journal of Pediatric Endocrinology and Metabolism (2019)
33. Identification of a Novel Frameshift Mutation in the Tecta Gene in an Iranian Family With Autosomal Nonsyndromic Hearing Loss, Acta Medica Iranica (2021)
34. Whole Exome Sequencing Reveals a Xpnpep3 Novel Mutation Causing Nephronophthisis in a Pediatric Patient, Iranian Biomedical Journal (2020)
35. Pkd2 Mutation in an Iranian Autosomal Dominant Polycystic Kidney Disease Family With Misleading Linkage Analysis Data, Kidney Research and Clinical Practice (2016)
36. Tcap Gene Is Not a Common Cause of Cardiomyopathy in Iranian Patients, European Journal of Medical Research (2023)
37. Gfap Variants Leading to Infantile Alexander Disease: Phenotype and Genotype Analysis of 135 Cases and Report of a De Novo Variant, Clinical Neurology and Neurosurgery (2021)
38. Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3, Journal of Clinical Neuromuscular Disease (2018)
39. Genotype, Phenotype and in Silico Pathogenicity Analysis of Hexb Mutations: Panel Based Sequencing for Differential Diagnosis of Gangliosidosis, Clinical Neurology and Neurosurgery (2018)
40. Crystallographic Modeling of the Pnpt1:C.1453A>G Variant As a Cause of Mitochondrial Dysfunction and Autosomal Recessive Deafness; Expanding the Neuroimaging and Clinical Features, Mitochondrion (2021)
41. A Novel Variant in the Pah Gene Causing Phenylketonuria in an Iranian Pedigree, Avicenna Journal of Medical Biotechnology (2017)
42. Alopecia Areata-Like Pattern of Baldness: The Most Recent Update and the Expansion of Novel Phenotype and Genotype in the Ctnnb1 Gene, Neurological Sciences (2023)